Cepheid, Inc., a leading molecular diagnostics company headquartered in the United States, has been at the forefront of rapid diagnostic testing since its founding in 1996. With a strong presence in North America, Europe, and Asia, Cepheid focuses on developing innovative solutions for infectious disease testing and genetic analysis. The company is renowned for its GeneXpert® system, which offers real-time PCR testing with unparalleled speed and accuracy. This unique platform enables healthcare providers to deliver timely results, significantly improving patient outcomes. Cepheid's commitment to advancing healthcare is reflected in its extensive portfolio of tests for conditions such as tuberculosis, COVID-19, and sexually transmitted infections. Recognised for its pioneering contributions to the diagnostics industry, Cepheid continues to solidify its market position through ongoing innovation and strategic partnerships, making it a trusted name in molecular diagnostics.
We don't have data for Cepheid, Inc., but we can show you information about their parent organization instead.
View parent company